Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use
With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in t...
Gespeichert in:
| Veröffentlicht in: | Cleveland Clinic journal of medicine 2023-03, Vol.90 (3), p.181-190 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 190 |
|---|---|
| container_issue | 3 |
| container_start_page | 181 |
| container_title | Cleveland Clinic journal of medicine |
| container_volume | 90 |
| creator | Fiffick, Alexa Nicole Iyer, Tara K Cochran, Tiffany Batur, Pelin |
| description | With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in the form of new pills, patches, and vaginal rings, and combined hormonal contraceptives that contain new estrogens as alternatives to ethinyl estradiol. We review updated prescribing methods for several established hormonal contraceptives such as depot medroxyprogesterone acetate, which is now available for subcutaneous self-injection. Additional choices of available contraceptive methods have important clinical implications that may remove unnecessary barriers to contraceptive use. |
| doi_str_mv | 10.3949/ccjm.90a.22075 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2781622829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2781622829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1355-3e98c3c2cbdc92c29a50a815035ce19ba1a4423eb745af7013c9de9bd60290f23</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EoqVw5Yh85ECCH3Fic6sqXlIlLvRsOZsNcpVHiRMk_j0uLVx2tJrZ0eoj5JqzVJrM3ANs29QwlwrBCnVC5txIkwidm1MyZ9rwhHPFZuQihC1jQnFhzslM5lrpnBdzUm52lRuR9h2FaRiwGyn03Tg4wN3ov6IRpe_CA11ScAGTMo6KVj7AFEJ0aF9TrGsPDr7vKDb-w5e-8WNcXFfRKeAlOatdE_DqqAuyeXp8X70k67fn19VynQCXSiUSjQYJAsoKjABhnGJOx-elAuSmdNxlmZBYFplydcG4BFOhKaucCcNqIRfk9tC7G_rPCcNo2_glNo3rsJ-CFYXmuRBamBhND1EY-hAGrO1u8K0bvi1nds_V7rnayNX-co0HN8fuqWyx-o__gZQ_cyt00g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2781622829</pqid></control><display><type>article</type><title>Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Fiffick, Alexa Nicole ; Iyer, Tara K ; Cochran, Tiffany ; Batur, Pelin</creator><creatorcontrib>Fiffick, Alexa Nicole ; Iyer, Tara K ; Cochran, Tiffany ; Batur, Pelin</creatorcontrib><description>With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in the form of new pills, patches, and vaginal rings, and combined hormonal contraceptives that contain new estrogens as alternatives to ethinyl estradiol. We review updated prescribing methods for several established hormonal contraceptives such as depot medroxyprogesterone acetate, which is now available for subcutaneous self-injection. Additional choices of available contraceptive methods have important clinical implications that may remove unnecessary barriers to contraceptive use.</description><identifier>ISSN: 0891-1150</identifier><identifier>EISSN: 1939-2869</identifier><identifier>DOI: 10.3949/ccjm.90a.22075</identifier><identifier>PMID: 36858617</identifier><language>eng</language><publisher>United States</publisher><subject>Contraception ; Contraceptive Agents ; Estrogens ; Female ; Humans ; Injections, Subcutaneous ; Pregnancy</subject><ispartof>Cleveland Clinic journal of medicine, 2023-03, Vol.90 (3), p.181-190</ispartof><rights>Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36858617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fiffick, Alexa Nicole</creatorcontrib><creatorcontrib>Iyer, Tara K</creatorcontrib><creatorcontrib>Cochran, Tiffany</creatorcontrib><creatorcontrib>Batur, Pelin</creatorcontrib><title>Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use</title><title>Cleveland Clinic journal of medicine</title><addtitle>Cleve Clin J Med</addtitle><description>With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in the form of new pills, patches, and vaginal rings, and combined hormonal contraceptives that contain new estrogens as alternatives to ethinyl estradiol. We review updated prescribing methods for several established hormonal contraceptives such as depot medroxyprogesterone acetate, which is now available for subcutaneous self-injection. Additional choices of available contraceptive methods have important clinical implications that may remove unnecessary barriers to contraceptive use.</description><subject>Contraception</subject><subject>Contraceptive Agents</subject><subject>Estrogens</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Subcutaneous</subject><subject>Pregnancy</subject><issn>0891-1150</issn><issn>1939-2869</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtPwzAQhC0EoqVw5Yh85ECCH3Fic6sqXlIlLvRsOZsNcpVHiRMk_j0uLVx2tJrZ0eoj5JqzVJrM3ANs29QwlwrBCnVC5txIkwidm1MyZ9rwhHPFZuQihC1jQnFhzslM5lrpnBdzUm52lRuR9h2FaRiwGyn03Tg4wN3ov6IRpe_CA11ScAGTMo6KVj7AFEJ0aF9TrGsPDr7vKDb-w5e-8WNcXFfRKeAlOatdE_DqqAuyeXp8X70k67fn19VynQCXSiUSjQYJAsoKjABhnGJOx-elAuSmdNxlmZBYFplydcG4BFOhKaucCcNqIRfk9tC7G_rPCcNo2_glNo3rsJ-CFYXmuRBamBhND1EY-hAGrO1u8K0bvi1nds_V7rnayNX-co0HN8fuqWyx-o__gZQ_cyt00g</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Fiffick, Alexa Nicole</creator><creator>Iyer, Tara K</creator><creator>Cochran, Tiffany</creator><creator>Batur, Pelin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230301</creationdate><title>Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use</title><author>Fiffick, Alexa Nicole ; Iyer, Tara K ; Cochran, Tiffany ; Batur, Pelin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1355-3e98c3c2cbdc92c29a50a815035ce19ba1a4423eb745af7013c9de9bd60290f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Contraception</topic><topic>Contraceptive Agents</topic><topic>Estrogens</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Subcutaneous</topic><topic>Pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fiffick, Alexa Nicole</creatorcontrib><creatorcontrib>Iyer, Tara K</creatorcontrib><creatorcontrib>Cochran, Tiffany</creatorcontrib><creatorcontrib>Batur, Pelin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cleveland Clinic journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fiffick, Alexa Nicole</au><au>Iyer, Tara K</au><au>Cochran, Tiffany</au><au>Batur, Pelin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use</atitle><jtitle>Cleveland Clinic journal of medicine</jtitle><addtitle>Cleve Clin J Med</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>90</volume><issue>3</issue><spage>181</spage><epage>190</epage><pages>181-190</pages><issn>0891-1150</issn><eissn>1939-2869</eissn><abstract>With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in the form of new pills, patches, and vaginal rings, and combined hormonal contraceptives that contain new estrogens as alternatives to ethinyl estradiol. We review updated prescribing methods for several established hormonal contraceptives such as depot medroxyprogesterone acetate, which is now available for subcutaneous self-injection. Additional choices of available contraceptive methods have important clinical implications that may remove unnecessary barriers to contraceptive use.</abstract><cop>United States</cop><pmid>36858617</pmid><doi>10.3949/ccjm.90a.22075</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0891-1150 |
| ispartof | Cleveland Clinic journal of medicine, 2023-03, Vol.90 (3), p.181-190 |
| issn | 0891-1150 1939-2869 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2781622829 |
| source | MEDLINE; EZB Electronic Journals Library |
| subjects | Contraception Contraceptive Agents Estrogens Female Humans Injections, Subcutaneous Pregnancy |
| title | Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T09%3A48%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20on%20current%20contraceptive%20options:%20A%20case-based%20discussion%20of%20efficacy,%20eligibility,%20and%20use&rft.jtitle=Cleveland%20Clinic%20journal%20of%20medicine&rft.au=Fiffick,%20Alexa%20Nicole&rft.date=2023-03-01&rft.volume=90&rft.issue=3&rft.spage=181&rft.epage=190&rft.pages=181-190&rft.issn=0891-1150&rft.eissn=1939-2869&rft_id=info:doi/10.3949/ccjm.90a.22075&rft_dat=%3Cproquest_cross%3E2781622829%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2781622829&rft_id=info:pmid/36858617&rfr_iscdi=true |